Elucidation of The Effects and Underlying Mechanism of Aerobic Interval Training Combined With Liraglutide On Diabetic Cardiomyopathy

objective: This study intended to explore the hypoglycemic and cardioprotective effects of 8-week aerobic interval training combined with liraglutide and elucidate the underlying mechanisms. Method: Male Wistar rats were randomly divided into 5 groups - normal control (CON), diabetic cardiomyopathy (DCM), high-dose liraglutide (DH), low-dose liraglutide DL , and aerobic interval training combined with liraglutide (DLE). The cardiac function of rats ,the FBG the levels of fasting insulin (FIN), HbA 1c, the total collagen content , AGEs, the mRNA expression of myocardial remodeling genes BNP, GSK3β, α-MHC, and β-MHC ,the expression of GLP-1 and GLP-1R proteins, Insulin resistance (HOMA-IR) and beta-cell function (HOMA-β) was analyze. Results: During the intervention, the FBG in each intervention group signicantly decreased compared to the DCM group. After 8 weeks,the DH, DL, and DLE groups showed improved blood glucose-related indices and cleared the accumulated AGEs in the DCM groups. The heart function in the DLE groups was signicantly improved than that in the DH and DL groups. The relative expression of BNP mRNA in the DH, DL, and DLE groups signicantly reduced compared to the CON and the DCM group .Compared to the DCM group,the relative expression of α-MHC mRNA increased signicantly and β-MHC mRNA decreased notably in the myocardium of the DH, DL, and the DLE group.The expression of GLP-1 in the myocardial tissue of rats in the DH group was higher than that in the DL and DLE groups. GLP-1R expression in the myocardial tissue in the DLE group was higher than that in the DH , DL and the DCM groups . Conclusion: Liraglutide combined with AIT intervention signicantly reduced FBG and the uctuations in FBG, alleviated myocardial brosis, improved cardiac function in DCM rats, supporting the ecacy of


Introduction
Diabetic cardiomyopathy is a pathophysiological state induced by diabetes mellitus (DM) in which heart failure occurs in the absence of coronary artery disease, hypertension, and valvular heart disease [2].
Liraglutide stimulates insulin secretion, inhibits the secretion of glucagon, and suppresses appetite to reduce blood sugar levels [3]. Several guidelines in the United States and Europe have listed GLP-1 receptor agonists as second-line drugs for the treatment of diabetes [4,5]. The guidelines for the prevention and control of type 2 diabetes in China (2020 Edition) [6] are recommended that regardless of whether HbA 1c is within normal limits, type 2 diabetes patients with atherosclerotic cardiovascular disease or high cardiovascular risk should use GLP-1 receptor agonists .However, the treatment of diabetes is costly and may be a burden for the patients.
Exercise is one of the " ve carriages" for the treatment of diabetes. It increases insulin sensitivity and decreases blood sugar, lipids, and cardiovascular risk factors. Aerobic exercises combined with metformin therapy improved cardiopulmonary function and the quality of life in patients with insulin resistance [7].Rosiglitazone and aerobic exercise signi cantly improved insulin sensitivity in obese rats individually, and their combined treatment restores insulin sensitivity to normal levels in diabetic patients [8]. However, there are no reports on the mechanism underlying the hypoglycemic effect of liraglutide combined with exercise. In aerobic interval training (AIT),the oxygen debt and consumption can be used to estimate the ratio of aerobic to anaerobic energy supply and improve the body's aerobic capacity and the maximum rate of oxygen consumption (VO 2 max). Therefore, AIT is more suitable for the rehabilitation of cardiovascular patients. However, the effect of AIT combined with liraglutide on the heart functioning in DCM has not been reported.
Therefore, the current study intended to explore the protective effect of 8-week aerobic interval training combined with liraglutide on the heart of DCM rats, compare whether the effect of the combined intervention is superior to drug intervention alone, and explore its underlying mechanism.

Experimental Results
Changes in FBG of rats during the 8-week intervention At wk0, the FBG levels of the diabetic rats were not signi cantly different (P > 0.05) but were signi cantly higher than those in the CON group (P < 0.01), indicating that the diabetes model was successfully established. At wk1, the FBG levels of rats in the DH, DL, and DLE groups were signi cantly lower than those in the DCM group (P < 0.05). The FBG of the rats in the DH group decreased the most compared to the DL and DLE groups but the differences were not signi cant (P > 0.05). In wk2, the FBG levels of the rats in the DH and DL groups increased slightly but those in the DLE group continued to decrease. After wk2, FBG was monitored once every two weeks. FBG decreased to varying degrees in the groups. The FBG of rats in the DH and DL groups altered to a certain extent but those in the DLE group decreased steadily. The FBG levels in each of the intervention groups were signi cantly lower than those in the DCM group (P < 0.05). The FBG levels of rats in the CON group remained stable throughout the 8 weeks.(in Fig.

2)
Comparison of related indices of the serum metabolites across the experimental groups After 8 weeks of intervention, the levels of FBG, HOMA-IR, and HbA 1c increased and HOMA-β decreased signi cantly in the DCM group compared to the CON group (P < 0.01). However, the levels of FINs were not signi cantly different across the groups (P > 0.05). Compared to the DCM group, the DH, DL, and DLE groups demonstrated a signi cant decrease in the levels of FBG, HOMA-IR, and HbA 1c (P < 0.01) and an increase in the HOMA-β (P < 0.01). The levels of FINs in the DH group were higher than those in the DCM group (P < 0.05). Although the levels of FINs in other groups were higher than the DCM group, the differences were not signi cant (P > 0.05).(in Table2)  Comparison of the heart function of rats across the groups After 8 weeks of intervention, the results of echocardiography showed that compared to the control group, the EF, FS, and CO of the rats decreased signi cantly (P < 0.01), the E/A ratio increased signi cantly (P < 0.01), and IVRT increased but not signi cantly (P > 0.05) in the DCM group. Compared to the DCM group, the DH, DL, and DLE groups showed a signi cant decrease in the E/A ratio (P < 0.05), and a signi cant increase in EF (P < 0.05). The FS of the DLE group was higher than that of the DCM group (P > 0.05), and the EF was signi cantly higher than that of the DH and DL groups (P > 0.05). No signi cant changes were observed in LVEDD, LVESD, and IVRT (P > 0.05) across the groups.(in Table3)  Comparison of the morphology of the rat myocardial tissue across the experimental groups The myocardial tissues from each experimental group were stained with H&E and the tissue morphology was observed using a light microscope. In the control group, the myocardial cells were arranged neatly and densely, the myocardial bers were tightly connected, the staining was uniform, and there was no muscle ber dissolution. In the DCM group, the myocardium of rats showed damage and fractured myocardial bers, the myocardial bers were disordered, the muscle ber gap was signi cantly widened, and there was blood cell accumulation in the interstitial space. In the DH, DL, and DLE groups, the myocardial bers were neatly arranged without any breaks, the myocardial congestion was reduced, and the cell morphology was generally intact. The myocardial bers in the DLE group were thicker and the arrangement was tighter than that in the DH and DL groups.(in Fig. 3) Compared to the CON group, the total collagen in the myocardial tissue increased, the collagen arrangement was disordered, and a large number of collagen type I and III collagen bers were dispersed around the cardiomyocytes in the DCM group. In the DLE group, the total collagen decreased signi cantly (P < 0.05). The total collagen content in the DL group was lower than that in the DH group (P < 0.05). There were no signi cant differences across the DLE, DL, and DH groups (P > 0.05).(in Fig. 4) Comparison of the levels of myocardial AGEs across the experimental groups After 8 weeks, the level of AGEs in the myocardium of the rats in the DCM group was signi cantly higher than that in the CON group (P < 0.01). Compared to the DCM group, the DH, DL, and DLE groups demonstrated signi cantly lower levels of AGEs (P < 0.05) and those in the DL group were slightly higher than those in the DH and DLE groups ,but there were no signi cant differences(P > 0.05).(in Fig. 5) Comparison of the expression of genes related to central ventricular remodeling in the myocardial tissue The expression of ventricular remodeling genes BNP, GSK3β, α-MHC, and β-MHC in myocardial tissues was detected using RT-PCR (in Fig. 6).
After 8 weeks, the relative expression of BNP mRNA in the myocardium of the DCM group increased signi cantly compared to that in the CON group (P < 0.01). The DH, DL, and DLE groups showed a signi cant decrease in the relative expression of BNP mRNA (P < 0.01) compared to the DCM group but there were no signi cant differences across the DH, DL, and DLE groups (P > 0.05).
After 8 weeks, compared to the CON group, the relative expression of GSK3β mRNA in the myocardium of the DCM group increased signi cantly (P < 0.01). The DH, DL, and DLE groups demonstrated a signi cant decrease in the relative expression of GSK3β mRNA (P < 0.01) compared to the DCM group but there were no signi cant differences across the DH, DL, and DLE groups (P > 0.05).
After 8 weeks, compared to the CON group, the relative expression of α-MHC mRNA was signi cantly lower in the DCM group (P < 0.05). The relative expression of α-MHC mRNA was signi cantly increased in the DH, DL, and DLE groups compared to the DCM group (P < 0.01). The relative expression of α-MHC mRNA in the DLE group was signi cantly higher than that in the CON group (P < 0.05) but there were no signi cant differences across the DH, DL, and DLE groups (P > 0.05).
After 8 weeks, the DCM group demonstrated a signi cant increase in the relative expression of β-MHC mRNA compared to the CON group (P < 0.01). The relative expression of β-MHC mRNA decreased in the DH, DL, and DLE groups compared to the DCM group (P < 0.01) but there were no signi cant differences across the three groups (P > 0.05).
Comparison of GLP-1/GLP-1R protein expression in the myocardium across the experimental groups After 8 weeks, the relative expression of GLP-1 protein in the myocardial tissue in the DCM group was signi cantly lower than that in the CON group (P < 0.05). The expression of GLP-1 signi cantly increased in the DH, DL, and DLE groups compared to the DCM group (P < 0.01). The expression of GLP-1 in the DH group was higher than that in the DL and DLE groups but the differences were not signi cant (P > 0.05).
(in Fig. 7) After 8 weeks, the expression of GLP-1R in myocardial tissue in the DCM group was lower than that in the CON group but the difference was not statistically signi cant (P > 0.05). The expression of GLP-1R increased signi cantly in the DH, DL, and DLE groups compared to that in the DCM (P < 0.01) and the CON groups. The DLE group showed signi cantly higher GLP-1R expression than the DH and DL groups but the differences across the DH, DL, and DLE groups were not signi cant (P > 0.05).

Analysis And Discussion
Liraglutide combined with AIT reduced the blood sugar levels in the DCM rats The results of the current study showed that the blood glucose levels in the DH and DL groups decreased in the rst week of the intervention followed by an insigni cant increase from the second week, and then there was a small range within which the blood sugar level uctuated. The blood glucose levels in the DLE group decreased throughout the 8 weeks. Fluctuations in blood glucose levels may cause an increase in the C-reactive protein levels, activate oxidative stress signaling pathways, directly damage cardiomyocytes, and lead to cardiomyocyte apoptosis [10]. Liraglutide and AIT markedly reduce HbA 1c levels, decrease insulin resistance, and improve pancreatic β-cell function to a certain extent. Administration of liraglutide promotes insulin secretion and inhibits the secretion of glucagon [11], thereby, lowering blood sugar levels. Exercise increases peripheral insulin sensitivity and glucose transport across the skeletal muscles via GLUT4 and reduces blood sugar levels [12]. In 2017, in a Danish study, diabetic patients were given liraglutide therapy individually and in combination with aerobic exercise therapy. The results showed that the combined intervention restored the HbA 1c levels in diabetic patients [13]. In terms of the stability of the blood sugar levels, joint intervention not only decreases blood sugar quickly but also avoids the uctuations therein.
Liraglutide combined with AIT reduced the AGEs and myocardial brosis and improved the cardiac structure in DCM rats In a high-glucose environment, AGEs play an important role in the pathogenesis of diabetes.The accumulation of AGEs, and exercise reduces them [14]. The study by Panteleeva and Rogozkin showed that exercise signi cantly reduced the content of AGEs in diabetic rats [15]. The study by Di et al. also showed that liraglutide lowered the extent of phenotypic changes in the coronary artery smooth muscles caused by AGEs by inhibiting the NF-κB signaling pathway [16]. Exercise and liraglutide treatment reduce the content of AGEs in the body but there are no reports on the effect of the combination of the two on AGEs. The current study showed that diabetes leads to an increase in the content of AGEs in the myocardium and liraglutide combined with AIT signi cantly eliminated AGEs in the myocardium and maintained the stability of the extracellular matrix. . Another study con rmed that exercise training reduces collagen accumulation in the myocardium of diabetic rats [19]. Treadmill exercises for 4 weeks markedly reduced the accumulation of collagen in the myocardium and lowered the expression of type and type collagen [20]. The results of our current study were consistent with these aforementioned results. After the 8-week intervention of liraglutide combined with AIT, type I and type III collagen in the myocardium reduced, indicating that the process of myocardial brosis can be effectively controlled to protect the heart.
Glycogen synthase kinase-3 (GSK-3) is a widely expressed and highly conserved serine/threonine kinase. In addition to regulating glycogen synthesis, GSK3β is involved in the pathogenesis of diabetes and the progression of myocardial brosis [21]. The expression of GSK3β in the myocardium of STZ-induced diabetic rats increased signi cantly after 28 days [22], which was consistent with the results of our study. Evidence suggests that GSK3β regulates the SMAD-3/TGF-β1 [23]signaling pathway and activates the AMPK/GSK3β/NFR2 signaling pathway to achieve the anti-brotic effect and alleviate cardiomyocyte apoptos. It can decrease atrial natriuretic peptide and markedly improve the left ventricular function to protect the morphology and function of the heart. [24,25] The results of the current study show that liraglutide alone and in combination with AIT reduced the expression of myocardial GSK3β and inhibited the accumulation of myocardial collagen bers, thereby alleviating myocardial brosis and protecting the diabetic heart.
Liraglutide combined with AIT increased myocardial contractility and improved cardiac function The initial damage to the myocardium due to diabetes affects the diastolic function, and as the disease progresses, systolic dysfunction develops [26]. The occurrence of heart failure is due to the primary or secondary weakening of myocardial contractility, which is related to the structure of tropomyosin. The head of the tropomyosin is composed of a myosin heavy chain (MHC), which is divided into α and β subunits. The ATPase activity of the α subunit is higher than that of the β subunit [27]. Rundell et al. showed that the expression of β-MHC increased and that of α-MHC decreased in STZ-induced animals, decreasing the tension of myocardial ber and myocardial contractility [28]. In the current study, the changes in the heavy chain subtypes of tropomyosin in the myocardium of diabetic rats affected the normal excitation-contraction coupling, which corresponded to a dysfunction in the myocardial contraction as shown by a decrease in LVEF and FS. In diabetic rats, insulin or carnitine linear transferase inhibitor improved the expression of myocardial α-MHC [29]. Exercise intervention reduced myocardial brosis and apoptosis by reducing the expression of β-MHC [30]. Liraglutide, alone and in combination with AIT, signi cantly decreased the relative expression of β-MHC mRNA and increased that of α-MHC mRNA. Exercise training may have improved the excitability of sympathetic nerves and acetylcholine promoting the expression of α-MHC mRNA [31]. On the one hand, exercise stress increases the relative expression of α-MHC mRNA and myocardial contractility in the heart. On the other hand, it increases the traction on the heart, resulting in compression of the ventricular wall, which increases BNP. BNP is produced by the ventricle. It is produced when the ventricular wall is compressed during ventricular pressure or volume overload. As a grade I risk factor for heart failure, the progression of diabetes is positively correlated with BNP [32]. When the duration of diabetes in mice reached 2 months, the BNP level increased [33]. The results of our study are consistent with these. In our study, the serum BNP levels of diabetic rats were signi cantly higher than that of the control rats after 10 weeks of establishing the diabetic model. GLP-1 signi cantly reduced the level of BNP in patients with type 2 diabetes [34]. The results of our study are consistent with these results. A meta-analysis showed that both aerobic and resistance exercises reduced the level of BNP in patients with heart failure [35]. Our study showed that 8 weeks of liraglutide intervention signi cantly reduced the level of BNP in the myocardium of diabetic rats. Compared to the DH and DL groups, the intramyocardial BNP levels in the DLE group were slightly higher.
Although there were no signi cant differences across the DH, DL, and DLE groups, the three groups showed a signi cant decline in the myocardial BNP levels of DCM rats. Therefore, liraglutide intervention in combination with AIT, on the one hand, increases the relative expression of α-MHC mRNA and myocardial contractility, and on the other, reduces the strain on the myocardium due to the excitement of the sympathetic nerve due to exercise. It also decreases the blood BNP levels, showing a neutralizing effect.

Liraglutide combined with AIT activated the GLP-1/GLP-1R signaling pathway and protected the DCM heart
Liraglutide is produced by the non-covalent binding of GLP-1 and albumin [36]. The half-life of liraglutide is relatively long, up to 13 hours [37]. In the diabetic patients who were administered liraglutide, the left ventricular mass index was signi cantly lesser than that in the control group, and the left ventricular endsystolic volume and left ventricular end-diastolic volume were lower, suggesting that liraglutide prevents left ventricular remodeling in diabetic patients [38]. Noyan-Ashraf and others tested the proteins that regulate myocardial survival [39]. The study found that 200 µg liraglutide injection twice a day for 1 week increased the activities of AKT, GSK3β, and PPARα, thereby improving the survival of diabetic mice after myocardial infarction, and this effect was independent of liraglutide's weight-lowering and blood-sugarlowering effects. This result was consistent with the results of our study. The expression levels of GLP-1 and GLP-1R in the myocardial tissue of diabetic rats were signi cantly lower than those in the control group. Both high and low doses of liraglutide increased the expression of GLP-1 and GLP-1R and decreased the level of GSK3β in the myocardium. The level of GLP-1 in the high-dose group was higher than that in the low-dose group but the GLP-1R level was not signi cantly different from that in the lowdose group. However, in the current study, the expression levels of GLP-1R in the high-dose and low-dose groups of liraglutide were inconsistent with those of GLP-1, which may be due to receptor desensitization. GPCRs bind to the receptor but the short-term or long-term attenuation of the cell signal response is due to receptor desensitization [41]. This partly explains why there were no signi cant differences related to improvement in the heart function between high-and low-dose liraglutide groups. This also explains the clinical resistance that arises during the treatment of diabetes, and the need to continuously increase the dose of medicine to maintain a stable blood sugar level. When liraglutide is combined with AIT, the expression of GLP-1R increased signi cantly, indicating that exercise improves receptor sensitivity. Therefore, the combined intervention shows complementary advantages in decreasing myocardial lipids, brosis, and myocardial hypertrophy and improving cardiac function.

Conclusion
Liraglutide combined with AIT intervention signi cantly reduced myocardial brosis, increased the expression of GLP-1/GLP-1R in the myocardium, myocardial contractility, and cardiac function, and improved the morphology and functioning of the heart in 8 weeks.

Model and grouping
The study was conducted in accordance with the Hebei Province Experimental Animal Management Regulations and Use of Laboratory Animals and the protocol was approved by the Animal Ethics Committee of the Hebei General Hospital(NO.2020101),and every effort was made to minimize both the number of animals used and their suffering. All the experiments were also performed and reported in accordance with the ARRIVE guidelines 2.0.Wistar rats (8 weeks old, bodyweight 250-280 g) were divided into 5 groups -normal control group (CON, n = 10), diabetic cardiomyopathy group (DCM, n = 10), highdose liraglutide group (DH, n = 10), low-dose liraglutide group (DL, n = 10), and aerobic interval training combined with liraglutide group (DLE, n = 10). After feeding them with high-fat for 4 weeks, a small dose of STZ (35 mg/kg) was injected intraperitoneally, and two consecutive fasting blood glucose (FBG) measurements ≥ 11.1 mmol/L indicated that the diabetes model was established. After establishing the diabetes model, the drug and exercise intervention was conducted for 8 weeks. During the intervention, the CON group was fed ordinary feed and the rest of the groups were fed a high-fat diet ad libitum.

Intervention plan Drug Intervention Program
The rats in the DH group were administered 0.4 ml/kg/day liraglutide and those in the DL and DLE groups were administered 0.2 ml/kg/day liraglutide. An equal volume of saline was administered to the rats in the CON group for 8 weeks.(in Fig. 1)

Exercise intervention program
The exercise intervention program adopted AIT using a treadmill. The exercise time was 60 min and it was set during the dark cycle, in consideration of the animals' biological rhythm, from 20 o'clock to 21 o'clock. The rats were provided 1 week of adaptive training, and AIT training was initiated in the second week. The exercise intensity was 25 m/min and the exercise time was 7 min. The intermittent period was active rest at 15 m/min for 3 min and was repeated 4 times.

Blood index test
Tail vein blood was collected before the intervention (wk0), and in the rst (wk1), second (wk2), fourth (wk4), sixth (wk6), and eighth week (wk8) of the intervention to test the FBG. Blood was drawn from the heart apex. It was centrifuged at a low temperature at 3500 rpm for 15 min to separate the serum and stored at -20°C. The levels of FBG, FINs, and HbA 1c were measured. Insulin resistance (HOMA-IR) and beta-cell function (HOMA-β) were calculated using the following equations -

Histological examination
After the blood was drawn, starting from the aorta, the circulatory system was ushed with pre-cooled normal saline containing diethyl pyrocarbonate (DEPC). The heart was removed, and 5 mm³ of the myocardial tissue from the upper and lower midpoints of the symmetrical plane perpendicular to the long axis of the left ventricle of the heart was resected. Then the tissue was xed with 4% paraformaldehyde, embedded in para n, and stained with H&E and Sirius red.

Tissue homogenate testing
About 50-mg tissue at the apex of the rat heart was resected and rinsed with pre-cooled saline. Then, 500 µl saline was added, and 10% of the tissue was homogenized using a homogenizer (IKA Tlobasic, Germany) and an ultrasonic cell crusher (Scientz-IID, Xinzhi, Ningbo, China). The homogenate was centrifuged at 3500 rpm for 15 min at 4°C. Then, the supernatant was aspirated, and the amount of advanced glycation end products (AGEs) was determined.
Real-time quantitative PCR detection of ventricular remodeling genes Myocardial tissue (100 mg) was resected and 1 ml of trizol reagent was added to extract the RNA. First Strand cDNA Synthesis Kit (Thermo) was used to obtain cDNA according to the manufacturer's instructions. Then, real-time PCR was performed using SYBR Green (Roche) using Mastercycler ep realplex PCR instrument (Eppendorf), where the reaction system was 25 µl. Each sample was subjected to real-time PCR in triplicates. The primer sequences used for PCR ampli cation are shown (in Table 1). Western blotting was performed to measure the expression of myocardial GLP-1/GLP-1R Myocardial tissue (30 mg) was treated with 300 µl of RIPA lysis buffer to extract the total protein in the myocardial cells. Protein concentration was determined using the BCA method. About 20 µg protein was added to each well and SDS-PAGE electrophoresis was performed. The bands were transferred 300 mA to polyvinylidene uoride (PVDF) membranes. Primary antibodies against GLP-1 (1:500), GLP-1R (1:100), and β-tubulin (1:1000) were added and the membranes were incubated at 4°C overnight [9].The secondary antibody, diluted 1:3000, was added and the membranes were incubated at room temperature for 2 h. Chemiluminescence (ECL) imaging was performed. ImageJ was used to analyze the images, and βtubulin was used as an internal reference to compare the optical density values across the groups of bands.
Statistical analysis SPSS 20.0 was used for statistical analysis. The Schapiro-Wilk normal distribution test was performed.
Data are expressed as mean ± standard deviation (M ± SD). ANOVA was used for comparison between groups. Signi cance thresholds used were P < 0.05 and P < 0.01.

Ethics Statement
The study was conducted in accordance with the Hebei Province Experimental Animal Management Regulations and Use of Laboratory Animals and the protocol was approved by the Animal Ethics The changes in FBG levels in the experimental groups during the intervention Note 1: One-way analysis of variance was performed; *, P < 0.05 compared to the CON group; #, P < 0.05 compared to the DCM group.

Figure 3
Comparison of myocardial tissue morphology across the experimental groups  Comparison of the levels of cardiac AGEs across the experimental groups. Note 5: One-way analysis of variance was performed. **, P < 0.01 compared to the CON group. #, P < 0.05; ##, P < 0.01 compared to the DCM group.

Figure 6
The relative mRNA expression of BNP, GSK3β, α-MHC, and β-MHC across the experimental groups. Note 6: One-way analysis of variance was performed; **, P < 0.01 compared to the CON group; ##, P < 0.01 #P 0.05 compared to the DCM group.

Figure 7
The relative expression of GLP-1 and GLP-1R across the experimental groups. Note 7: One-way analysis of variance was performed. *, P < 0.05; **, P < 0.01 compared to the CON group. ##, P < 0.01 compared to the DCM group.